Which closed-end funds own Rhythm Pharmaceuticals Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $24.8M. Security type: common equity. Country: United States. CUSIP 76243J105 · ISIN US76243J1051 · ticker RYTM.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 1.04% | $11.3M | 101,573 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.61% | $4.2M | 38,140 sh | $690M | 3.5% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.52% | $3M | 27,009 sh | $573M | 3.7% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.46% | $6.3M | 56,806 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “RYTM” → · Compare two funds’ portfolios →